Unusual outcome of disseminated candidiasis treated with fluconazole:: A matter of pharmacokinetics?

被引：2
|
作者：
Faucher, JF [1 ]
Thiébaut, MM [1 ]
Reynes, J [1 ]
Janbon, F [1 ]
机构：
[1] Hop Gui de Chauliac, Serv Malad Infect & Trop, F-34295 Montpellier 5, France
来源：
CLINICAL INFECTIOUS DISEASES | 1998年 / 26卷 / 01期
关键词：
D O I：
10.1086/517064
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [31] Population pharmacokinetics of fluconazole given for secondary prevention of oropharyngeal candidiasis in HIV-positive patients
    Csajka, C
    Décosterd, LA
    Buclin, T
    Pagani, JL
    Fattinger, K
    Bille, J
    Biollaz, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (10) : 723 - 727
  • [32] Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis
    Arikan, S
    Akova, M
    Hayran, M
    Özdemir, O
    Erman, M
    Gür, D
    Ünal, S
    CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) : 903 - 908
  • [33] Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit
    Healy, CM
    Baker, CJ
    Zaccaria, E
    Campbell, JR
    JOURNAL OF PEDIATRICS, 2005, 147 (02): : 166 - 171
  • [34] Comparison of the Kidney Fungal Burden in Experimental Disseminated Candidiasis by Species of the Candida parapsilosis Complex Treated with Fluconazole, Amphotericin B and Caspofungin in a Temporarily Neutropenic Murine Model
    Szilagyi, J.
    Foeldi, R.
    Gesztelyi, R.
    Bayegan, S.
    Kardos, G.
    Juhasz, B.
    Majoros, L.
    CHEMOTHERAPY, 2012, 58 (02) : 159 - 164
  • [35] CANDIDA FUNGUS BALLS IN THE COMMON BILE-DUCT - UNUSUAL MANIFESTATION OF DISSEMINATED CANDIDIASIS
    MAGNUSSEN, CR
    OLSON, JP
    ONA, FV
    GRAZIANI, AJ
    ARCHIVES OF INTERNAL MEDICINE, 1979, 139 (07) : 821 - 822
  • [36] Favorable outcome of chronic disseminated candidiasis in four pediatric patients with hematological malignancies
    Donker, Albertine E.
    Mavinkurve-Groothuis, Annelies M. C.
    van Die, Lya E.
    Verweij, Paul E.
    Hoogerbrugge, Peter M.
    Warris, Adilia
    MEDICAL MYCOLOGY, 2012, 50 (03) : 315 - 319
  • [37] Successful treatment of chronic disseminated candidiasis with fluconazole and a granulocyte-macrophage colony-stimulating factor combination
    Rókusz, L
    Liptay, L
    Kádár, K
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2001, 33 (10) : 784 - 786
  • [38] Fluconazole Population Pharmacokinetics and Dosing for Prevention and Treatment of Invasive Candidiasis in Children Supported with Extracorporeal Membrane Oxygenation
    Watt, Kevin M.
    Gonzalez, Daniel
    Benjamin, Daniel K., Jr.
    Brouwer, Kim L. R.
    Wade, Kelly C.
    Capparelli, Edmund
    Barrett, Jeffrey
    Cohen-Wolkowiez, Michael
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 3935 - 3943
  • [39] Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial
    Leroux, S.
    Jacqz-Aigrain, E.
    Elie, V.
    Legrand, F.
    Barin-Le Guellec, C.
    Aurich, B.
    Biran, V.
    Dusang, B.
    Goudjil, S.
    Coopman, S.
    Sanchez, R. Garcia
    Zhao, W.
    Manzoni, P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (09) : 1989 - 1999
  • [40] EFFICACY OF FLUCONAZOLE IN THE TREATMENT OF UPPER GASTROINTESTINAL CANDIDIASIS IN NEUTROPENIC PATIENTS WITH CANCER - FACTORS INFLUENCING THE OUTCOME
    AKOVA, M
    AKALIN, HE
    UZUN, O
    HAYRAN, M
    TEKUZMAN, G
    KANSU, E
    ASLAN, S
    TELATAR, H
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (03) : 298 - 304
12345